An article on Alzheimer's disease progression, in the context of SDG 3, focusing specifically on the dynamics of soluble TREM2 and its association with amyloid and tau markers, neuroimaging features, and cognition.
An article on dementia risk, in the context of SDGs 3 and 10, focusing specifically on the association between ethnicity, socioeconomic deprivation, and dementia risk.
In vitro and in vivo studies showed that melatonin therapy is effective against AD. The emerging novel melatonin-based therapies are potential treatment options in AD.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing insight on a group of inherited disorders that have an effect on the RPE-photoreceptor complex and choriocapillaris, causing a range of symptoms and in many cases gradual visual loss.
This chapter briefly reviews the history of ketamine, explores proposed mechanisms of action, outlines data pertaining to efficacy and safety, and considers “real-world” usage and the challenges to implementation.
This chapter clearly defines “treatment-resistant depression (TRD)” and “difficult-to-treat depression (DTD)" to help clinicians to understand how to treat patients with depression.
Elsevier,
Healthcare Strategies and Planning for Social Inclusion and Development, Volume 2: Social, Economic, and Health Disparities of Rural Women, 2022, Pages 115-158
This chapter focuses on how good quality foods prevent malnutrition in all its forms.
Ukrainian Refugees' experience at Cancer Centers in Poland and Italy.
A Viewpoint article on the unfolding health and humanitarian crisis due to the conflict in Ukraine, in the context of SDGs 3 and 16, focusing specifically on the impact on people with HIV and opioid use disorder.
The Lancet Nigeria Commission supports SDG 3 by repositioning future health policy in Nigeria to achieve universal health coverage and better health for all, and presents the evidence to support a positive and realistic future for Nigeria.